Identification of high and middle penetrance pathogenic variants in patients with hereditary breast/ovarian cancer by multigene panel analysis

被引:0
|
作者
Ryu, Jin-Sun [1 ]
Cho, Eun Hae [2 ]
Yoon, Kyong-Ah [3 ]
Lee, Eun-Gyeong [1 ]
Lee, Eun-Sook [1 ]
Kong, Sun-Young [1 ]
机构
[1] Natl Canc Ctr, Goyang, South Korea
[2] Green Cross Genome, Yongin, South Korea
[3] Konkuk Univ, Seoul, South Korea
关键词
D O I
10.1158/1538-7445.AM2019-1405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1405
引用
收藏
页数:2
相关论文
共 50 条
  • [31] A portrait of germline pathogenic variants in high and moderate penetrance breast cancer genes in Brazil
    Oliveira, Leandro Jonata de Carvalho
    Rodrigues, Amanda Muniz
    Fernandes, Carolina de Bustamante
    do Rego, Fernanda Orpinelli Ramos
    Koyama, Fernanda Christtanini
    Souto, Andreza Karine de Barros Almeida
    Santana, Thaiana Aragao
    de Faria, Joao Paulo Gonzaga
    Bulcao, Marcela Lima
    Nascimento, Ivana Lucia de Oliveira
    Silva, Ana Carolina Branco Neves
    Goncalves, Isabela Pessoa Elias
    Maia, Rayana Elias
    de Azevedo, Renata Gondim Meira Velame
    Galindo, Layla Testa
    Pachito, Daniela Vianna
    Cury, Adriana
    Zalis, Mariano Gustavo
    Ferrari, Bruno Lemos
    Garicochea, Bernardo
    Dienstmann, Rodrigo
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [32] Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer.
    Kapoor, Nimmi S.
    Curcio, Lisa D.
    Blakemore, Carlee A.
    Bremner, Amy K.
    McFarland, Rachel E.
    West, John G.
    Banks, Kimberly C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [33] Role of the multi-gene panel testing for detection of pathogenic variants in patients with hereditary bilateral breast cancer
    Filorizzo, C.
    Fanale, D.
    Incorvaia, L.
    Barraco, N.
    Bono, M.
    Brando, C.
    Calo, V.
    Cancelliere, D.
    Cucinella, A.
    Dimino, A.
    Fiorino, A.
    Magrin, L.
    Pedone, E.
    Perez, A.
    Pivetti, A.
    Sammataro, S.
    Sciacchitano, R.
    Vaccaro, G.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S432 - S433
  • [34] Evaluation of criteria for genetic study of hereditary breast and ovarian cancer BRCAX families by multigene panel testing
    Castillo-Guardiola, V.
    Sarabia-Meseguer, M. D.
    Macias-Cerrolaza, J. A.
    Garcia-Aliaga, A.
    Rosado-Jimenez, L.
    Sanchez-Bermudez, A. I.
    Zafra-Poves, M.
    Moreno-Locubiche, M. A.
    Pascual-Gilabert, P.
    Aliaga-Bano, A.
    Noguera-Velasco, J. A.
    Ayala De La Pena, F.
    Ruiz-Espejo, F.
    CLINICA CHIMICA ACTA, 2019, 493 : S576 - S577
  • [35] Multigene panel testing in breast/ovarian cancer patients reveals high prevalence of FANCM truncating variants and suggests an oligogenic disease course in the carriers
    Jakimovska, M.
    Kubelka-Sabit, K.
    Karagjozov, M.
    Lazarova, E.
    Smichkoska, S.
    Plaseska-Karanfilska, D.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1564 - 1564
  • [36] Multigene panel testing for hereditary breast and ovarian cancer syndrome: experience from a tertiary referral hospital
    Potrony, Miriam
    Morales-Romero, Blai
    Moreno, Lorena
    Pastor, Belen
    Villanueva-Canas, Jose L.
    Badenas, Celia
    Aragon Manrique, Isabel
    Carrasco Salas, Pilar
    Aguilera, Paula
    Ferrer-Mileo, Laura
    Gaba, Lydia
    Adamo, Barbara
    Oriola, Josep
    Sanchez, Aurora
    Puig-Butille, Joan A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 400 - 400
  • [37] Frequency of pathogenic variants in Fanconi anemia genes in hereditary breast and ovarian cancer families
    Stegel, Vida
    Klancar, Gasper
    Anzic, Nina
    Skerl, Petra
    Dragos, Vita Setrajcic
    Bombac, Alenka
    Klasinc, Anja Zagozen
    Vogric, Vesna
    Krajc, Mateja
    Blatnik, Ana
    Strojnik, Ksenja
    Banjac, Marta
    Novakovic, Srdjan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 394 - 394
  • [38] Clinical evaluation of multigene testing for hereditary breast and ovarian cancer
    Ellisen, Leif
    Kurian, Allison
    Lincoln, Stephen
    Desmond, Andrea
    Mills, Meredith
    Shannon, Kristen
    Gabree, Michelle
    Anderson, Michael
    Kobayashi, Yuya
    Monzon, Federico
    Ford, James
    CANCER RESEARCH, 2015, 75
  • [39] Technical evaluation of multigene testing for hereditary breast and ovarian cancer
    Lincoln, Stephen
    Kurian, Allison
    Desmond, Andrea
    Nilsen, Geoffrey
    Jacobs, Kevin
    Yang, Shan
    Hart, Reece
    Monzon, Federico
    Ellisen, Leif
    Ford, James
    CANCER RESEARCH, 2015, 75
  • [40] Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility
    Quezada Urban, Rosalia
    Diaz Velasquez, Clara Estela
    Gitler, Rina
    Rojo Castillo, Maria Patricia
    Sirota Toporek, Max
    Figueroa Morales, Andrea
    Moreno Garcia, Oscar
    Garcia Esquivel, Lizbeth
    Torres Mejia, Gabriela
    Dean, Michael
    Delgado Enciso, Ivan
    Diaz Lopez, Hector Ochoa
    Rodriguez Leon, Fernando
    Jan, Virginia
    Garzon Barrientos, Victor Hugo
    Ruiz Flores, Pablo
    Espino Silva, Perla Karina
    Haro Santa Cruz, Jorge
    Martinez Gregorio, Hector
    Rojas Jimenez, Ernesto Arturo
    Romero Cruz, Luis Enrique
    Mendez Catala, Claudia Fabiola
    Alvarez Gomez, Rosa Maria
    Fragoso Ontiveros, Veronica
    Alonso Herrera, Luis
    Romieu, Isabelle
    Ignacio Terrazas, Luis
    Irasema Chirino, Yolanda
    Frecha, Cecilia
    Oliver, Javier
    Perdomo, Sandra
    Vaca Paniagua, Felipe
    CANCERS, 2018, 10 (10):